Q1 2023 Holdings
Filed 2023-05-15 | 58 holdings | $3.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $115.9M | 5,352,183 | 3.7% |
| Morphic Hldg Inc | COM | 61775R105 | $144.8M | 3,846,966 | 4.7% |
| Xencor Inc(XNCR) | COM | 98401F105 | $147.3M | 5,282,516 | 4.7% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $163.7M | 7,521,024 | 5.3% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $164.0M | 4,244,645 | 5.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $359.6M | 5,451,647 | 11.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $413.4M | 2,999,453 | 13.3% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $561.5M | 11,584,280 | 18.1% |